STAR-LIFE: a Post-market Registry on MINIject

Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

NCT01823965 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Failing Blebs With Ranibizumab

NCT00570726 ·Status: COMPLETED ·Phase: PHASE1

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

NCT03244657 ·Status: UNKNOWN ·Phase: PHASE4

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

NCT01580020 ·Status: COMPLETED ·Phase: PHASE4

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

NCT00804934 ·Status: COMPLETED

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

NCT05576792 ·Status: COMPLETED

Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study

NCT06048185 ·Status: ACTIVE_NOT_RECRUITING

Lucentis for New Onset Neovascular Glaucoma

NCT00727038 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing

NCT02127684 ·Status: WITHDRAWN ·Phase: PHASE2

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)

NCT00424710 ·Status: COMPLETED ·Phase: PHASE1

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

NCT04332133 ·Status: COMPLETED ·Phase: NA

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

NCT02396316 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

NCT00429962 ·Status: COMPLETED ·Phase: PHASE3

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

NCT03105609 ·Status: TERMINATED

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma

NCT01370135 ·Status: COMPLETED ·Phase: NA

Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy

NCT01256632 ·Status: COMPLETED ·Phase: NA

Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity

NCT05701124 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

NCT00567697 ·Status: COMPLETED ·Phase: PHASE3

The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity

NCT02304068 ·Status: COMPLETED ·Phase: NA

Ranibizumab for Myopic Neovascularization

NCT01246089 ·Status: UNKNOWN ·Phase: PHASE4

To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema

NCT01846299 ·Status: COMPLETED ·Phase: PHASE3

A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration

NCT05126966 ·Status: WITHDRAWN ·Phase: PHASE3

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration

NCT00395707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema

NCT00387582 ·Status: COMPLETED ·Phase: PHASE2

Combination of Ranibizumab and Targeted Laser Photocoagulation

NCT04444492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3